Archives

by in
Entry Author Date Location
Six Takeaways from Boston’s Life Science Disruptors 10/13/14 Boston
Sold For Parts, Accelerator Grad Allozyne Reaches End of the Line 09/18/14 Seattle
Scholar Rock’s Local Approach to Immune Disease Nabs $20M 09/15/14 Boston
John Maraganore: From “Prototypical Geek” To Canny Alnylam Chief 09/07/14 Boston
West Coast Biotech Roundup: ARCH, Ebola, ViaCyte, Calithera & More 08/28/14 San Francisco
ARCH Venture Exploits IPO Window To Raise $400M Fund, Its Eighth 08/27/14 Seattle
Coelacanths And Other IPO Thoughts Before The Autumn Markets Return 08/26/14 National
To Take On New York, Accelerator Makes Big Changes 08/14/14 New York
West Coast Biotech Roundup: MappBio, Juno, Zosano, and More 08/07/14 San Diego
With $310M and Public Investors Aboard, Is a Juno IPO Next? 08/05/14 Seattle
East Coast Biotech Roundup: Emulate, Accelerator, Retrophin, & More 08/01/14 Boston
Seattle Jobs? Big Biotech Gives And Takes Away (Mostly The Latter) 07/29/14 Seattle
Accelerator Bags $51M, Makes Long-Awaited Move to NYC 07/29/14 New York
East Coast Biotech Roundup: Acceleron, Seres, Sage, & More 07/18/14 Boston
Sage, Despite Industry-Wide Pullback, Scores $90M in Upsized IPO 07/17/14 Boston
Who Needs Biotech VCs, Anyway? 07/15/14 San Francisco
BIO 2014: An Industry Surrounded by Insurmountable Opportunity 06/19/14 San Diego
Sage Therapeutics Readies IPO Pitch to Develop CNS Drugs 06/18/14 Boston
Amid Court Fight and Trial Pauses, Juno Closes First Round at $176M 04/24/14 Seattle
Just 7 Tickets Left for Our What’s Hot in Cancer Event April 22 04/21/14 Seattle
Agios’s Blood Cancer Drug Shines in First Clinical Test 04/06/14 Boston
East Coast Biotech Roundup: ImmusanT, NY Disruptors, Tesaro, & More 03/14/14 Boston
Sage Therapeutics Grabs $38M More For CNS Drugs 03/13/14 Boston
SAGE Therapeutics Lands $38,000,000 Series C Round 03/13/14 Boston
Join Xconomy for ‘What’s Hot in Cancer Immunotherapy’ on April 22 02/20/14 Seattle
The Young and Proven Biotech VCs From 2012. Where Are They Now? 02/10/14 National
Juno Therapeutics Receives $120,000,000 Series A Financing Round 12/05/13 Seattle
Juno Therapeutics Grabs $120M to Coax Immune System to Fight Cancer 12/03/13 Seattle
East Coast Biotech Roundup: Pronutria, Alzheon, Nextcode, & More 10/25/13 Boston
NextCODE Lands $15,000,000 Series A Funding Round 10/24/13 Boston
Page 1 of 13 next page »